Outcomes Using MARS for Patients With ALF

NCT05594953 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-03-27

No results posted yet for this study

Summary

Retrospective chart review will be conducted on patients at Methodist Dallas Medical Center, meeting the inclusion criteria from January 1, 2019 to December 15, 2020 to determine the transplant free survival and overall survival and other secondary outcome measures.

Conditions

  • Alcoholic Hepatitis
  • Acute Liver Failure

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Parvez Mantry, MD · Methodist

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-23
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05594953 on ClinicalTrials.gov